International Journal of Nanomedicine (Jul 2019)

Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors [Corrigendum]

  • Wu H,
  • Infante JR,
  • Keedy VL,
  • Jones SF,
  • Chan E,
  • Bendell JC,
  • Lee W,
  • Kirschbrown WP,
  • Zamboni BA,
  • Ikeda S,
  • Kodaira H,
  • Rothenberg ML,
  • Burris III HA,
  • Zamboni WC

Journal volume & issue
Vol. Volume 14
pp. 5751 – 5752

Abstract

Read online

Wu H, Infante JR, Keedy VL, et al. Int J Nanomedicine. 2015:10;1201—1209 On page 1208, Disclosure section, “The authors report no conflicts of interest in the work” has been updated since publication. Read the original article